Curaleaf Holdings Future Growth
Future criteria checks 4/6
Curaleaf Holdings is forecast to grow earnings and revenue by 59.6% and 10.2% per annum respectively. EPS is expected to grow by 55.3% per annum. Return on equity is forecast to be 15.9% in 3 years.
Key information
59.6%
Earnings growth rate
55.3%
EPS growth rate
Pharmaceuticals earnings growth | 23.4% |
Revenue growth rate | 10.2% |
Future return on equity | 15.9% |
Analyst coverage | Good |
Last updated | 03 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,777 | 195 | 137 | 252 | 2 |
12/31/2025 | 1,556 | -12 | 118 | 164 | 10 |
12/31/2024 | 1,409 | -110 | 63 | 122 | 16 |
12/31/2023 | 1,347 | -230 | 5 | 75 | N/A |
9/30/2023 | 1,402 | -457 | 1 | 85 | N/A |
6/30/2023 | 1,395 | -426 | -27 | 84 | N/A |
3/31/2023 | 1,377 | -382 | -127 | 15 | N/A |
12/31/2022 | 1,275 | -258 | -88 | 46 | N/A |
9/30/2022 | 1,244 | -157 | -137 | 22 | N/A |
6/30/2022 | 1,234 | -202 | -150 | 11 | N/A |
3/31/2022 | 1,232 | -223 | -170 | -7 | N/A |
12/31/2021 | 1,196 | -206 | -230 | -58 | N/A |
9/30/2021 | 1,118 | -164 | -201 | -27 | N/A |
6/30/2021 | 984 | -90 | -237 | -89 | N/A |
3/31/2021 | 790 | -57 | -127 | 8 | N/A |
12/31/2020 | 627 | -57 | -114 | 12 | N/A |
9/30/2020 | 472 | -52 | -110 | -25 | N/A |
6/30/2020 | 351 | -50 | -86 | 5 | N/A |
3/31/2020 | 282 | -72 | -110 | -23 | N/A |
12/31/2019 | 221 | -67 | -120 | -38 | N/A |
9/30/2019 | 178 | -57 | -124 | -37 | N/A |
6/30/2019 | 137 | -84 | -121 | -50 | N/A |
3/31/2019 | 103 | -64 | -101 | -45 | N/A |
12/31/2018 | 77 | -56 | -78 | -33 | N/A |
9/30/2018 | 51 | -40 | -49 | -20 | N/A |
6/30/2018 | 36 | -6 | -33 | -10 | N/A |
3/31/2018 | 25 | -3 | -25 | -10 | N/A |
12/31/2017 | 19 | -3 | -18 | -8 | N/A |
12/31/2016 | 4 | 0 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CURL.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: CURL.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CURL.F is expected to become profitable in the next 3 years.
Revenue vs Market: CURL.F's revenue (10.2% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: CURL.F's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CURL.F's Return on Equity is forecast to be low in 3 years time (15.9%).